Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

Amar Gajjar, Murali Chintagumpala, David Ashley, Stewart Kellie, Larry E. Kun, Thomas E. Merchant, Shaio Woo, Greg Wheeler, Valerie Ahern, Matthew J. Krasin, Maryam Fouladi, Alberto Broniscer, Robert Krance, Gregory A. Hale, Clinton F. Stewart, Robert Dauser, Robert A. Sanford, Christine Fuller, Ching Lau, James M. BoyettDana Wallace, Richard J. Gilbertson

Research output: Contribution to journalArticlepeer-review

597 Scopus citations

Fingerprint Dive into the research topics of 'Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial'. Together they form a unique fingerprint.

Medicine & Life Sciences